Reckitt Benckiser Group (OTCMKTS:RBGLY) Hits New 52-Week High - Here's What Happened

Key Points

• Reckitt Benckiser Group shares reached a new 52-week high of $15.20, indicating strong investor interest with a trading volume of 162,805 shares.
• Analysts are bullish on the stock, with Sanford C. Bernstein upgrading it to a "strong-buy" and a consensus average rating of "Buy" from several research reports.
• Financial indicators show a debt-to-equity ratio of 1.08, suggesting moderate leverage, alongside a quick ratio of 0.39 and a current ratio of 0.58, indicating potential liquidity concerns.

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) hit a new 52-week high on Wednesday . The stock traded as high as $15.20 and last traded at $15.20, with a volume of 162805 shares trading hands. The stock had previously closed at $15.18.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on RBGLY shares. Sanford C. Bernstein upgraded Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research report on Thursday, June 5th. Royal Bank Of Canada reiterated an "outperform" rating on shares of Reckitt Benckiser Group in a research report on Friday, July 25th. Two analysts have rated the stock with a hold rating, two have given a buy rating and four have given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy".

Reckitt Benckiser Group Price Performance

The company has a 50-day moving average of $13.95 and a 200 day moving average of $13.40. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.39 and a current ratio of 0.56.

Reckitt Benckiser Group Cuts Dividend

The firm also recently announced a dividend, which will be paid on Thursday, September 25th. Investors of record on Monday, August 11th will be given a dividend of $0.2106 per share. This represents a yield of 341.0%. The ex-dividend date is Friday, August 8th.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.